Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Univest Corp. of PA (UVSP) & Civeo Corp (CVEO): 2 Stocks Insiders are Buying in Droves

Univest Corp. of PA (NASDAQ:UVSP) & Civeo Corp (NYSE:CVEO) are two stocks in which massive insider buying has been seen recently. Civeo Corp (NYSE:CVEO)’s stock plunged drastically to $12.84, on September 29, from its September 26 close of $25.47. On September 30, three insiders of the company acquired thousands of its shares. An insider of Univest Corp. of PA (NASDAQ:UVSP) has been purchasing huge quantities of the stock under his spouse name. Let’s take a closer look at each of these insider trades.


Civeo Corp (NYSE:CVEO) at current price is valued at $1.34 billion in market cap. Bradley J Dodson, President & CEO of Civeo Corp (NYSE:CVEO) purchased 24,000 shares of the company at an average price of $12.86 per share. With this purchase, Dodson now owns a total of 322,519 shares of the company. Two directors of the company, Mayank Ashar and Gary L Rosenthal also purchased 8,000 shares each at an average price of $12.81 and $12.21 respectively on the same day. Civeo Corp (NYSE:CVEO)’s shares plunged drastically on Monday September 29, after the company announced that it was abandoning its plans of becoming a REIT and will instead redomicile in Canada for saving on taxes. David Einhorn’s Greenlight Capital is one of the hedge funds that are bullish on the stock. The hedge fund bought 6.15 million shares of Civeo Corp (NYSE:CVEO) during second quarter of 2014. Based on last declared quarterly results, Civeo Corp (NYSE:CVEO) has an EPS of $1.27 and currently trades at 9.95 times earnings

Univest Corp. of PA (NASDAQ:UVSP) is a $307 million market cap, holding company for Univest Bank and Trust Co, a regional bank. On September 26, 29 and 30, Thomas Scannapieco, a director of Univest Corp. of PA (NASDAQ:UVSP) purchased several shares of the company under his Spouse’ name. On September 26, Scannapieco purchased 2,300 shares at an average price of $18.86 per share, on September 29 he purchased 6,000 shares at an average price of $18.85 per share, and on September 30he again purchased another 7,700 shares of the company at an average price of $19.05 per share. With these purchases, Scannapieco now owns a total of 33,480 shares of Univest Corp. of PA (NASDAQ:UVSP) through his wife, he also owns 11,020 shares of the company under his own name. Bernard Horn’s Polaris Capital Management and Ken Gray and Steve Walsh’s Bryn Mawr Capital are two of the largest shareholders in the company. As of June 30, 2014, Polaris Capital Management owns over 120,000 shares and Bryn Mawr Capital owns over 290,000 shares of Univest Corp. of PA (NASDAQ:UVSP). Based on last declared quarterly results, the company has an EPS of $1.32 and trades at 14.33 times earnings, very near to the average industry P/E of 14.35.

Warren Buffett and BillionairesFree Report: Warren Buffett and 12 Billionaires Are Crazy About These 7 Stocks

Let Warren Buffett, David Einhorn, George Soros, and David Tepper WORK FOR YOU. If you want to beat the low cost index funds by an average of 6 percentage points per year look no further than Warren Buffett’s stock picks. That’s the margin Buffett’s stock picks outperformed the market since 2008. In this free report, Insider Monkey’s market beating research team identified 7 stocks Warren Buffett and 12 other billionaires are crazy about. CLICK HERE NOW for all the details.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!